Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
SOLO BRANDS INC (SBDS)
OTCConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
$2.99-0.33%
Close 2026-11-04 · 1-day change
OTCConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
12.80 → 12.80 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for SBDS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Resolve NYSE delisting notice | A primary condition in SOLO BRANDS INC's published investment case. The stated target is NYSE delisting notice resolved by end 2026. | Under Pressure | NYSE delisting notice remains unresolved past FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround thesis, not a proven durable growth story. The thesis is in watch mode: recent progress on costs and profitability is encouraging, but earnings quality remains weak and overall risk is high.
The evidence describes SBDS as cheap versus peers, but confidence in that valuation signal is low. The negative expectations gap suggests the market may already reflect demanding expectations, while the snapshot gives no share-price figure or clear measure of how much recovery is assumed.
Near term, the results show mixed but meaningful cost progress: the net loss narrowed, adjusted EBITDA improved, and operating expenses and inventory declined. International sales and distribution also showed early progress, though this priority is new and recent financial performance remains weak relative to the industry cohort.
The multi-year thesis depends on whether cost discipline and improving profitability continue, while international expansion produces sustained sales growth. Near term, a guidance cut would be a meaningful negative; continued strength or weakness among consumer discretionary bellwethers could also affect the sector backdrop. Total and market risk have risen, adding to the uncertainty.
Over the next 1 to 3 years, SBDS is a high-risk turnaround case with real signs of cost improvement but limited evidence yet of a durable recovery. The long-term thesis hinges on continued execution and stronger results. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| They also plan to raise gross profit above $32.9M. |
| Improving |
| Gross profit stays below $32.9M beyond next 4 quarters |
Gross profit: $53.019M FY2026-Q2; GAAP. Published target: Gross profit improves above $32.9M in next 4 quarters. Target period is not explicitly aligned with this observation. Aug 13, 202653,019,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve cash flow from operations | Management wants to improve cash flow from negative $16M in Q1. | Improving | Cash flow remains negative beyond next 4 quarters | Cash from operations: $36.074M FY2026-Q2; GAAP. Published target: Cash flow from operations improves to positive territory in next 4 quarters. Target period is not explicitly aligned with this observation. Aug 13, 202636,074,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$12.80 → $12.80 · observed estimates
$0.49B → $0.49B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-25 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-26 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-27 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-28 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-29 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-30 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-07-31 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-01 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-02 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-03 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-04 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-05 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-06 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-08 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-09 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-10 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-12 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-13 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-14 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-15 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-16 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-17 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-18 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-19 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-20 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-21 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-22 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-23 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-24 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-25 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-26 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-27 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-28 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-29 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-30 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-08-31 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-01 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-02 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-03 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-04 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-05 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-06 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-07 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-08 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-09 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-10 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-11 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-12 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-13 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-14 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-15 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-16 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-17 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-18 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-19 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-20 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-21 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-22 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-23 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-24 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-25 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-26 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-27 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-28 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-29 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-09-30 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-01 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-02 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-03 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-04 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-05 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-06 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-07 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-08 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-09 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-10 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-11 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-12 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-13 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-14 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-15 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-16 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-17 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-18 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-19 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-20 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-21 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-22 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-23 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-24 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-25 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-26 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-27 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-28 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-29 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-30 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-10-31 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-11-01 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-11-02 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-11-03 | $12.80 | $489,300,000 | 1 / 1 |
| 2026-11-04 | $12.80 | $489,300,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.